Rechallenge With PLD Added to Trabectedine in Recurrent Ovarian Cancer: a Multicenter Prospective Trial
Latest Information Update: 07 Aug 2023
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Trabectedin (Primary)
- Indications Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms MITO36; Reprab Study; REPRAB study - MITO 36
- 19 May 2021 New trial record